Antiplatelet drug therapy has become one of the cornerstones of treatment for patients with cardiovascular disease. Large clinical trials have shown that antiplatelet medications have important ...
Dental extraction is performed frequently and can be accompanied by perioperative or postoperative complications. Bleeding is among the most common and important issues to consider in the ...
Antiplatelet drugs are a group of powerful medicines that prevent blood clots. When you are wounded, platelets arrive on the scene and group together to form a clot that stops the bleeding. This is a ...
The factor XIa inhibitor asundexian reduced recurrent ischemic stroke without increasing major or minor bleeding in patients ...
WASHINGTON, DC—Compared with dual antiplatelet therapy (DAPT), taking a single antiplatelet following TAVI is associated with a lower rate of all-cause mortality and major bleeding at 6 months, ...
A research team led by Professors Joo-Yong Hahn, Young Bin Song, and Ki Hong Choi of the Division of Cardiology at Samsung ...
Antiplatelet agents form a cornerstone of therapy for patients with acute coronary syndrome undergoing percutaneous coronary intervention, as well as in the secondary prevention of cardiovascular ...
Atherosclerotic peripheral arterial disease is associated with an increased risk of myocardial infarction, stroke, and death from cardiovascular causes. Antiplatelet drugs reduce this risk, but the ...
Dual antiplatelet therapy (DAPT) combines medications used to treat conditions associated with blood clotting like a heart attack or stroke. These medications can also help prevent complications from ...
The appropriate duration of dual antiplatelet therapy in patients at high risk for bleeding after the implantation of a drug-eluting coronary stent remains unclear. One month after they had undergone ...
Anticoagulants and antiplatelet drugs eliminate or reduce the risk of blood clots. They can also treat blood clots by breaking them up. Some people may have side effects like increased bruising.